KAREN STUKES: Open Payments
NPI 1831376433 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 13 payments from 8 companies in 2025. Trend: 2023 $1,301 · 2024 $606 · 2025 $1,191
Food & beverage: $1,191
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 2 | $254 |
| Madrigal Pharmaceuticals | 2 | $229 |
| Otsuka America Pharmaceutical, Inc. | 4 | $143 |
| Novo Nordisk Inc | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $123 |
| Genentech USA, Inc. | 1 | $122 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $100 |
| Corcept Therapeutics | 1 | $96 |
Products named: REZDIFFRA, REXULTI, ULTOMIRIS, Wegovy, Kerendia, Xolair, NEFFY, Korlym.
Industry payments across NC — which companies pay providers there.
